Crystal arthropathies: recognizing and treating "the gouch".
Gout is a common disease and the prevalence is increasing. Chronic hyperuricemia (uric acid serum levels >6.8 mg/dL) is a key feature. Treating to a target uric acid level of 6.0 mg/dL is recommended. In addition to cochicine, probenecid, and allopurinol, feboxostat is a new option for urate-lowering therapy.
Department of Community Health and Family Medicine, University of Florida, 625 SW 4th Avenue, Gainesville, FL 32601, USA. quillen@ufl.edu
David M
DM
Quillen
D000493:Allopurinol / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D002908:Chronic Disease; D003078:Colchicine / Q000627:therapeutic use; D000069465:Febuxostat; D006073:Gout / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D006074:Gout Suppressants / Q000627:therapeutic use; D006801:Humans; D033461:Hyperuricemia / Q000188:drug therapy*; D011339:Probenecid / Q000627:therapeutic use; D013844:Thiazoles / Q000627:therapeutic use; D014527:Uric Acid / Q000378:metabolism*; D014528:Uricosuric Agents / Q000627:therapeutic use
D000963:Antimetabolites; D006074:Gout Suppressants; D013844:Thiazoles; D014528:Uricosuric Agents; D000069465:Febuxostat; D014527:Uric Acid; D000493:Allopurinol; D011339:Probenecid; D003078:Colchicine